These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19156669)

  • 1. Pharmacodynamics of glucose regulation by methylprednisolone. II. normal rats.
    Jin JY; Jusko WJ
    Biopharm Drug Dispos; 2009 Jan; 30(1):35-48. PubMed ID: 19156669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of glucose regulation by methylprednisolone. I. Adrenalectomized rats.
    Jin JY; Jusko WJ
    Biopharm Drug Dispos; 2009 Jan; 30(1):21-34. PubMed ID: 19156931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic modeling of methylprednisolone effects on body weight and glucose regulation in rats.
    Fang J; DuBois DC; He Y; Almon RR; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2011 Jun; 38(3):293-316. PubMed ID: 21394487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression.
    Ayyar VS; DuBois DC; Nakamura T; Almon RR; Jusko WJ
    J Pharmacol Exp Ther; 2019 Aug; 370(2):327-336. PubMed ID: 31197019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic modeling of the effects of glucocorticoids and circadian rhythms on adipokine expression.
    Sukumaran S; Jusko WJ; DuBois DC; Almon RR
    J Pharmacol Exp Ther; 2011 Jun; 337(3):734-46. PubMed ID: 21398515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids.
    Hazra A; Pyszczynski N; DuBois DC; Almon RR; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):643-67. PubMed ID: 17593325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.
    Ayyar VS; DuBois DC; Almon RR; Jusko WJ
    J Pharmacol Exp Ther; 2017 Oct; 363(1):45-57. PubMed ID: 28729456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-modeling of methylprednisolone effects on glucose regulation in rats.
    Fang J; Sukumaran S; Dubois DC; Almon RR; Jusko WJ
    PLoS One; 2013; 8(12):e81679. PubMed ID: 24312573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor/gene-mediated pharmacodynamic effects of methylprednisolone on phosphoenolpyruvate carboxykinase regulation in rat liver.
    Jin JY; DuBois DC; Almon RR; Jusko WJ
    J Pharmacol Exp Ther; 2004 Apr; 309(1):328-39. PubMed ID: 14722324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats.
    Ramakrishnan R; DuBois DC; Almon RR; Pyszczynski NA; Jusko WJ
    J Pharmacol Exp Ther; 2002 Jan; 300(1):245-56. PubMed ID: 11752123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.
    Ramakrishnan R; DuBois DC; Almon RR; Pyszczynski NA; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2002 Feb; 29(1):1-24. PubMed ID: 12194533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of methylprednisolone after intravenous and intramuscular administration in rats.
    Hazra A; Pyszczynski N; DuBois DC; Almon RR; Jusko WJ
    Biopharm Drug Dispos; 2007 Sep; 28(6):263-73. PubMed ID: 17569107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats.
    Yao Z; DuBois DC; Almon RR; Jusko WJ
    J Pharm Sci; 2008 Jul; 97(7):2820-32. PubMed ID: 17828751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism.
    Ayyar VS; Almon RR; DuBois DC; Sukumaran S; Qu J; Jusko WJ
    J Proteomics; 2017 May; 160():84-105. PubMed ID: 28315483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.
    Ayyar VS; Sukumaran S; DuBois DC; Almon RR; Qu J; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2018 Aug; 45(4):557-575. PubMed ID: 29704219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part I: Determination and Prediction of Dexamethasone and Methylprednisolone Tissue Binding in the Rat.
    Ayyar VS; Song D; DuBois DC; Almon RR; Jusko WJ
    J Pharmacol Exp Ther; 2019 Aug; 370(2):318-326. PubMed ID: 31197020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part III: Estrous Cycle and Estrogen Receptor-Dependent Antagonism of Glucocorticoid-Induced Leucine Zipper (GILZ) Enhancement by Corticosteroids.
    Ayyar VS; DuBois DC; Almon RR; Jusko WJ
    J Pharmacol Exp Ther; 2019 Aug; 370(2):337-349. PubMed ID: 31197018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-induced alterations of renal sulfate transport.
    Sagawa K; Darling IM; Murer H; Morris ME
    J Pharmacol Exp Ther; 2000 Aug; 294(2):658-63. PubMed ID: 10900245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of rat splenocyte proliferation with methylprednisolone: in vivo effect of liposomal formulation.
    Mishina EV; Jusko WJ
    Pharm Res; 1994 Jun; 11(6):848-54. PubMed ID: 7937524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical modeling of corticosteroid pharmacogenomics in rat muscle following acute and chronic methylprednisolone dosing.
    Yao Z; Hoffman EP; Ghimbovschi S; Dubois DC; Almon RR; Jusko WJ
    Mol Pharm; 2008; 5(2):328-39. PubMed ID: 18271548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.